Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormone therapy for trans individuals is effective and generally safe in the short term.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Lowering testosterone speeds up wound healing in male mice.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Finasteride improves hair loss in women with hyperandrogenism.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

New treatments for male hypogonadism are effective and should be personalized.

The three estrogen receptor genes are highly expressed in zebrafish neuromasts during development.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Some breast cancer chemotherapy can cause permanent hair loss.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Neurosteroids show promise for treating epilepsy and more research is needed.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.